Research programme: gene therapies - Human Genome Sciences/Genentech

Drug Profile

Research programme: gene therapies - Human Genome Sciences/Genentech

Alternative Names: Gene-based therapies - Human Genome Sciences/Genentech

Latest Information Update: 26 Oct 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Genentech; Human Genome Sciences
  • Class
  • Mechanism of Action Gene transference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Cancer; Immunological disorders; Neurological disorders

Most Recent Events

  • 26 Oct 2005 No development reported - Preclinical for Cancer in USA (unspecified route)
  • 26 Oct 2005 No development reported - Preclinical for Immunological disorders in USA (unspecified route)
  • 26 Oct 2005 No development reported - Preclinical for Neurological disorders in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top